Note: Ingredients listed on restricted chemical lists
EC/CAS
202-859-9/100-51-6
Name of the chemical
Benzyl Alcohol
Concentration
Proprietary
EC/CAS
200-334-9/57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
Proprietary
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
Balance
General Information
Revision date
2013-02-13
Product name
Sodium Ferric Gluconate Injection 62.5MG INJ 10x5 ML 10VL
Product Synonyms
NDC 00591-0149-87
Chemical name
For
supplier name
U.S
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
WATSON PHARMACEUTICALS, INC
e-mail address of the competent person responsible for the Safety Data Sheet
SafetyDataSheets@Actavis.com
GHS Information
Signal word
Not Applicable
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Not Applicable Not Applicable
Signal word
Not Applicable
Hazard statements
Not Applicable EU LABELING AND CLASSIFICATION 67/548/EEC: According to Article 1 of European Union Council Directive 92/32/EEC, medical products in the finished state for human use (as defined by European Union Council Directives 67/548/EEC and 87/21/EEC) are not subject to the regulations and administrative provisions of European Union Council Directive 92/32/EEC. Not Applicable
Precautionary statements
Not Applicable See Section 16 for full EU classification information of product and components and full text of hazard and precautionary statements. EMERGENCY OVERVIEW
Product definition
This product is a brown to dark brown, odorless liquid
Health hazards
The primary health hazard associated with occupational exposure to this product is the potential for irritation of contaminated eyes and mild irritation of contaminated skin, especially if contamination is repeated. The most commonly reported adverse reactions seen in therapeutic use include nausea, vomiting and/or diarrhea, injection site reaction, hypotension, cramps, hypertension, dizziness, abnormal blood effects, chest pain, leg cramps and pain. Reports of serious adverse reactions such as anaphylactic-type reactions, shock, loss of consciousness, convulsion have occurred from therapeutic use of this product. Other adverse effects seen from therapeutic use are described in
TOXICOLOGICAL INFORMATION
Flammability Hazards: When involved in a fire, this material may decompose and produce irritating vapors and toxic compounds (including carbon, iron and nitrogen oxides). Reactivity Hazards: This product is not reactive.
Environmental hazards
Large quantities released to the aquatic and terrestrial environment may have an adverse effect Emergency Considerations: Emergency responders should wear appropriate protection for the situation to which they respond.